Zantac -- also known as ranitidine -- was a popular heartburn drug until 2020, when the Food and Drug Administration ordered it removed from pharmacy shelves because of a potential cancer risk. While ...
British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer. GSK does not admit to any liability in ...
A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients. The three-day hearing ...